COMPOSITIONS AND METHODS OF USE OF ONCOLYTIC VIRUS LIKE VESICLES

The present invention relates to high-titer hybrid vims vectors which produce virus-like vesicle (VLVs) and compositions and methods thereof for targeting a malignancy or infectious disease. VLVs are a capsid-free, self-replicating artificial virus platform carrying positive-strand capped and polyadenylated RNA encoding an in vitro evolved Semliki Forest vims (SFV) RNA-dependent RNA replicase and the vesicular stomatitis virus (VSV) glycoprotein. The VLVs of the present invention and pharmaceutical compositions thereof encode for polynucleotide and/or polypeptide therapeutic agents useful in methods for the treatment, prophylaxis, and prevention of malignancies and infectious diseases..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 02. März Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

ALMASSIAN BIJAN [VerfasserIn]
NAKAAR VALERIAN [VerfasserIn]
MA XIANYONG [VerfasserIn]
MADINA BHASKARA REDDY [VerfasserIn]
WANG KEPENG [VerfasserIn]
YAROVINSKY TIMUR [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
bio
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
C12N: Microorganisms or enzymes; compositions thereof; pr (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-03-02, Last update posted on www.tib.eu: 2023-06-05, Last updated: 2023-06-14

Patentnummer:

US2023063041

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA016666321